← Back to Search

Prosthetic Suspension System

Ventilating vs Non-Ventilating Suspension Systems for Amputation

N/A
Waitlist Available
Research Sponsored by Össur Iceland ehf
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a new type of artificial limb attachment that lets air flow through to keep the skin cool and dry. It focuses on people with above-knee amputations to see if this new system improves skin health compared to regular attachments.

Who is the study for?
This trial is for individuals over 18 years old who have had a below-knee amputation and weigh between 50-136 kg. They should be able to understand instructions, use a prosthetic liner, and have been confident prosthetic users for more than three months. The study excludes those not fitting these criteria or unable to follow the protocol.
What is being tested?
The investigation compares two types of lower limb prosthetic suspension systems: one with ventilation (AeroFit Seal-In Liner/Socket) and one without (Seal-In Silicone Liner). It aims to assess user-reported benefits on skin health from using these systems in daily life.
What are the potential side effects?
While specific side effects are not listed, potential issues may include discomfort, skin irritation or damage due to the fit and function of the liners and sockets being tested.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Subject perceived skin health (PEQ-RLH)
Secondary study objectives
Incidents of prosthesis slippage, the need to remove liner to dry limb or liner and incidents of complete loss of suspension.
Subject perceived activity restriction and prosthesis use, TAPES-R
Subject perceived quality of life EQ-5D-5L

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Crossover BABExperimental Treatment2 Interventions
Group 1 starts using the ventilating suspension system (condition A), group 2 starts using non-ventilating suspension system (condition B) and then they cross-over to the other system, two times.
Group II: Crossover ABAExperimental Treatment2 Interventions
Group 1 starts using the ventilating suspension system (condition A), group 2 starts using non-ventilating suspension system (condition B) and then they cross-over to the other system, two times.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
AeroFit Seal-In Liner / Socket
2023
N/A
~60
Seal-In Silicone Liner
2023
N/A
~60

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for skin health, such as moisturizers and gentle cleansing techniques, primarily work by enhancing the skin's barrier function and maintaining hydration. Moisturizers containing ingredients like urea, glycerin, or glycyrrhetinic acid help to retain moisture and repair the skin barrier, which is crucial for preventing dryness and irritation. Gentle cleansing with weak wiping pressure, as opposed to ordinary pressure, preserves the skin's integrity and reduces the risk of damage, especially in vulnerable populations like older adults. These treatments are essential for skin health patients as they help to maintain the skin's protective functions, reduce the risk of infections, and improve overall comfort and quality of life.
Atopic dermatitis and the indoor climate. The effect from preventive measures.Effectiveness of weak wiping pressure during bed baths in hospitalized older adults: A single-blind randomized crossover trial.Evidence-based treatment of atopic dermatitis with topical moisturizers.

Find a Location

Who is running the clinical trial?

Össur Iceland ehfLead Sponsor
22 Previous Clinical Trials
3,851 Total Patients Enrolled
Össur EhfLead Sponsor
22 Previous Clinical Trials
3,851 Total Patients Enrolled

Media Library

AeroFit Seal-In Liner / Socket (Prosthetic Suspension System) Clinical Trial Eligibility Overview. Trial Name: NCT05925712 — N/A
Skin Health Research Study Groups: Crossover ABA, Crossover BAB
Skin Health Clinical Trial 2023: AeroFit Seal-In Liner / Socket Highlights & Side Effects. Trial Name: NCT05925712 — N/A
AeroFit Seal-In Liner / Socket (Prosthetic Suspension System) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05925712 — N/A
Skin Health Patient Testimony for trial: Trial Name: NCT05925712 — N/A
~23 spots leftby Nov 2025